+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

From
Pharmerging - Global Strategic Business Report - Product Thumbnail Image

Pharmerging - Global Strategic Business Report

  • Report
  • May 2025
  • 184 Pages
  • Global
From
Global Parkinson's Disease Drugs Market 2018-2024 - Product Thumbnail Image

Global Parkinson's Disease Drugs Market 2018-2024

  • Report
  • March 2019
  • 110 Pages
  • Global
From
Gastrointestinal Diseases Therapeutics Market 2024-2028 - Product Thumbnail Image

Gastrointestinal Diseases Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 174 Pages
  • Global
From
Drug Delivery Devices Market Report 2025 - Product Thumbnail Image

Drug Delivery Devices Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
From
Hidradenitis Suppurativa Market Report 2025 - Product Thumbnail Image

Hidradenitis Suppurativa Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
CD40 Ligand - Pipeline Review, H2 2019 - Product Thumbnail Image

CD40 Ligand - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 74 Pages
  • Global
From
Hidradenitis Suppurativa - Pipeline Insight, 2025 - Product Thumbnail Image

Hidradenitis Suppurativa - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 115 Pages
  • Global
From
Loading Indicator